KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Inventory (2016 - 2025)

Historic Inventory for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q3 2025 value amounting to $1.6 billion.

  • Vertex Pharmaceuticals' Inventory rose 5065.75% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 5065.75%. This contributed to the annual value of $1.2 billion for FY2024, which is 6315.65% up from last year.
  • Vertex Pharmaceuticals' Inventory amounted to $1.6 billion in Q3 2025, which was up 5065.75% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Inventory registered a high of $1.6 billion during Q3 2025, and its lowest value of $298.9 million during Q1 2021.
  • For the 5-year period, Vertex Pharmaceuticals' Inventory averaged around $733.0 million, with its median value being $603.5 million (2023).
  • In the last 5 years, Vertex Pharmaceuticals' Inventory skyrocketed by 1339.64% in 2022 and then surged by 7740.86% in 2023.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Inventory stood at $353.1 million in 2021, then skyrocketed by 30.44% to $460.6 million in 2022, then skyrocketed by 60.4% to $738.8 million in 2023, then soared by 63.16% to $1.2 billion in 2024, then soared by 34.96% to $1.6 billion in 2025.
  • Its Inventory stands at $1.6 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.4 billion for Q1 2025.